Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment

University of Maryland, Baltimore

Winship Cancer Institute, Emory University, Atlanta

Mount Sinai Medical Center, New York

Sarah Cannon Cancer Center, Nashville

Illinois Cancer Care, Peoria

University of Kansas Cancer Center, Clinical Research Center, Fairway

University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City

Mary Crowley Cancer Research Centers Medical City, Dallas

Institute of Oncology Hematology Biomedical Research, Laredo

University of Texas Health Science Center San Antonio, San Antonio

University Health Network, Toronto